What Creative Peptides does

Creative Peptides is a privately held peptide Contract Development and Manufacturing Organization (CDMO) founded in 2005, headquartered in Shirley, New York, with a European office in Kriftel, Germany. The company provides custom peptide synthesis, peptide modification, custom conjugation services, cGMP-compliant peptide manufacturing, and end-to-end CDMO services spanning process development through commercial supply. Its core technology stack rests on solid-phase peptide synthesis (SPPS) with Fmoc chemistry, supporting linear, cyclic, stapled, disulfide-rich, macrocyclic, and long-chain peptides as well as non-natural amino acids and peptidomimetics, complemented by an extensive modification and conjugation portfolio covering PEGylation, lipidation, fluorophore labeling, click chemistry, bioconjugation, and peptide-oligonucleotide, peptide-polymer, peptide-carrier protein, peptide-fatty acid, peptide-imaging agent, peptide-enzyme, and nanoparticle conjugations.

Beyond chemistry services, the company has positioned four proprietary technology platforms as strategic differentiators: the IntraCellular Delivery System (ICDS™) for intracellular transport of therapeutic payloads, the Integrated Long-Acting Peptide Technology Platform, the Peptide-Oligonucleotide Conjugation (POC) Platform bridging peptide and nucleic acid therapeutics, and an AI-based Peptide Drug Discovery and Structure Analysis Platform supporting virtual screening and design optimization. It also operates a catalog business covering therapeutic peptides, cosmetic peptides, amino acids, cell-penetrating peptides, antimicrobial peptides, MHC-peptide tetramers, and PNA products, sold through an online storefront.

The business model is B2B project-based services with quote-based pricing that varies by sequence complexity, purity (70–98%+), modifications, scale (milligram research through kilogram GMP), and regulatory requirements. GMP work is contracted on multi-year supply terms while research-grade and modification services are largely pay-as-you-go. GTM is hybrid: direct enterprise field sales for CDMO and conjugation engagements, supplemented by a self-serve website channel for catalog and smaller research orders. Customers span pharmaceutical and biotechnology companies (primary), life science research organizations, and cosmetic/personal care companies, with operations and marketing reaching a global footprint via the US and German offices.

Name

Creative Peptides

Legal name

Creative Peptides

Website

https://creative-peptides.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Creative Peptides is a private peptide CDMO offering custom synthesis, modification, conjugation, and cGMP manufacturing services — from milligram research to kilogram commercial scale — to pharmaceutical, biotechnology, life science research, and cosmetic companies globally, with proprietary platforms for intracellular delivery, long-acting peptides, and AI-assisted drug discovery.

Ownership category

akta.pro rank

Product category

Peptide Contract Development and Manufacturing (CDMO)

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Therapeutic Peptides & Protein/Peptide Biologics (HLAAAAAH)

akta.pro secondary industries

Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL), Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG)

Keywords

• Custom peptide synthesis
• Peptide CDMO services
• CGMP peptide manufacturing
• Peptide conjugation services
• Peptide modification services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Custom Peptide Synthesis Services: Project-based custom peptide synthesis services ranging from milligram to kilogram scale. Pricing based on peptide length, complexity, purity requirements, and modification needs. Services include feasibility assessment, custom synthesis, and analytical validation.
2. GMP Peptide Manufacturing: GMP-compliant peptide manufacturing for clinical and commercial supply with regulatory documentation and quality systems. Long-term manufacturing partnerships and supply continuity services.
3. Peptide CDMO Services: Contract development and manufacturing organization services covering process development, scale-up, and GMP manufacturing. End-to-end support from lab to commercial scale with integrated services.
4. Catalog Peptide Products: Off-the-shelf peptide products including therapeutic peptides, cosmetic peptides, functional peptides, and high-throughput screening tools available through online ordering.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Creative Peptides is a peptide Contract Development and Manufacturing Organization (CDMO) that provides custom peptide synthesis, peptide modification, peptide conjugation, peptide library construction and screening, and cGMP-compliant peptide manufacturing for pharmaceutical, biotechnology, life science research, and cosmetic customers. Offerings span research-grade to GMP-grade peptides at scales from milligrams to kilograms, supported by proprietary platforms including ICDS™ intracellular delivery and AI-based peptide drug discovery.

Product overview

Creative Peptides is a CDMO (Contract Development and Manufacturing Organization) specializing in high-quality peptide synthesis, modification, conjugation, and manufacturing under cGMP compliance. The company's offering is a platform-plus-modules architecture centered on core synthesis and modification services (Custom Peptide Synthesis, Peptide Modification Services, Custom Conjugation Service, cGMP Peptide Service, Peptide CDMO) supplemented by specialized platforms (IntraCellular Delivery System ICDS™, Integrated Long-Acting Peptide Technology Platform, AI-based Peptide Drug Discovery Platform, Peptide Library Construction and Screening). The product portfolio spans research-grade to GMP-grade peptides across therapeutic peptides (APIs, cyclic peptides, peptide inhibitors), cosmetic peptides (anti-aging, anti-wrinkle, hair growth), functional peptides (antimicrobial, cell-penetrating, targeting, PNA), amino acids and derivatives, and catalog peptides. Conjugation services cover nanoparticles, oligonucleotides, polymers, carrier proteins, fatty acids, imaging agents, and small molecules. The company supports drug discovery, clinical development, and cosmetic innovation through integrated end-to-end services from design through commercial-scale manufacturing.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Peptide Synthesis Custom synthesis of peptides using solid-phase peptide synthesis (SPPS) technology, supporting linear, cyclic, stapled, and D-/L-amino acid peptides from milligram to kilogram scale; targeted at pharmaceutical, biotechnology, life science research, and cosmetic customers.
• Peptide Modification Services Comprehensive peptide modification services including glycopeptides synthesis, PNA backbone modification, N/C-terminal modifications, biotinylated peptides, PEGylation, fluorescence labeling, post-translational modifications, peptide lipidation, and cyclic peptide synthesis; for pharmaceutical, biotech, and research customers.
• Custom Conjugation Service Peptide conjugation services spanning peptide-drug conjugates, PEGylation, lipidation, protein coupling, peptide-oligonucleotide, peptide-antibody, and nanoparticle-peptide conjugates; for pharma, biotech, and research customers.
• cGMP Peptide Manufacturing Service GMP-compliant peptide manufacturing with quality systems and documentation for clinical and commercial supply; targeted at pharmaceutical and biotechnology companies.
• Peptide CDMO Services Contract development and manufacturing organization services covering end-to-end peptide solutions from lab to commercial scale, including synthesis, process development, and GMP manufacturing; for pharmaceutical and biotechnology partners.
• Peptide Library Construction and Screening Peptide library services including phage display, AI-based peptide drug discovery, animal peptide library, nanocyclic peptide library, peptide chip screening, and virtual peptide library for drug discovery applications; for pharma and biotech customers.
• Peptide Analysis Services Comprehensive analytical services including biological testing, chemical/physical analyses, peptide binding affinity analysis, purity analysis, structural analysis, SPRi service, epitope mapping, peptide characterization, and amino acid analysis; for pharma, biotech, and research customers.
• Custom MHC-Peptide Tetramer Service Custom services for biotinylated pMHC monomer production, custom antigen peptide synthesis, HLA/Peptide Tetramer development, fluorescent labeling, MHC binding peptide screening, and tetramer-based antigen-specific T cell detection; for immunology research customers.
• Targeting Peptide Custom Services Custom targeting peptide synthesis, design, screening, modification, conjugation, quality testing, purification, and targeted delivery system customization; for pharma, biotech, and research customers.
• IntraCellular Delivery System (ICDS™) Proprietary intracellular delivery system designed to overcome membrane barriers and enable efficient intracellular transport of peptides, proteins, and nucleic acids; offered as a technology platform to pharmaceutical and biotechnology customers.
• Integrated Long-Acting Peptide Technology Platform Technology platform for designing long-acting peptides using lipidation-based approaches to extend half-life and improve therapeutic profiles; offered to pharmaceutical and biotechnology customers developing peptide therapeutics.
• AI-based Peptide Drug Discovery and Structure Analysis Platform AI-powered platform for peptide drug discovery and structural analysis supporting virtual screening, design optimization, and predictive modeling for therapeutic peptide candidates; offered to pharma and biotech customers.
• Cosmetic Peptides Catalog peptides for cosmetic applications including anti-aging, anti-pigmentation, anti-wrinkle, eye care, and hair growth formulations; for cosmetic and personal care companies.
• Therapeutic Peptides Catalog therapeutic peptide products including APIs, cyclic peptides, peptide inhibitors, and tumor antigen-derived peptides for pharmaceutical research.
• Amino Acids Catalog amino acid products including standard amino acids and derivatives, glycosylated amino acids, protected amino acids, stable isotope labeled amino acids, and other specialty amino acids.
• Cell Penetrating Peptides Catalog cell-penetrating peptides designed to facilitate cellular uptake and membrane translocation of biologically active molecules; for research and drug delivery applications.
• Antimicrobial Peptides Catalog host defense peptides (5-40 amino acids) with natural antibiotic properties for research and therapeutic development.
• Peptide Nucleic Acid (PNA) Catalog synthetic PNA analogs with peptide-like backbones offering high binding affinity and chemical stability for gene-targeting and diagnostics.
• Peptide Inhibitors Catalog peptide-based inhibitors with high affinity and specificity used in drug discovery and research applications.
• MHC-Peptide Tetramer Catalog MHC-Peptide Tetramer complexes formed by binding four copies of a specific peptide with MHC molecules for T cell detection and immunology research.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Qualified Partner LaboratoriessupportingOthersPartner laboratories provide optional biological evaluation and functional testing support including cellular uptake studies, gene silencing efficiency assays, nuclease resistance testing, and in vivo biodistribution studies to complement chemical conjugation services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bachem: Global leader in peptide CDMO services and APIs, including custom synthesis, GMP manufacturing, and oligonucleotide peptide conjugates. Directly comparable to Creative Peptides across nearly the full service stack, but at substantially larger scale.
• PolyPeptide Group: Specialty CDMO focused on custom peptide and oligonucleotide manufacturing for pharma and biotech. Closely comparable in service portfolio, with established GMP capacity and a broader customer base than Creative Peptides.
• GenScript: Offers custom peptide synthesis, gene synthesis, and protein services through its life-science CDMO arm. Overlaps significantly with Creative Peptides' research-grade and GMP peptide offerings and serves a similar biotech customer base.
• CPC Scientific: Peptide-focused CDMO providing custom synthesis, GMP manufacturing, and peptide modification services. A close head-to-head competitor in custom and GMP peptide services, particularly in the US market.
• CSBio: Peptide synthesis and GMP manufacturing CDMO with peptide synthesizer manufacturing. Competes with Creative Peptides in custom peptide production and contract manufacturing.
• AnaSpec (Eurogentec): Provider of custom peptides, antibodies, and biochemical reagents with GMP capabilities. Overlaps with Creative Peptides in custom peptide synthesis, modifications, and labeling services for research customers.

Emerging players

• AAPPTec: Specializes in peptide synthesis reagents, resins, and custom peptide services with a research-grade focus. Comparable to Creative Peptides' catalog and research-grade peptide offerings, though smaller in GMP scope.

Broad incumbents

• Lonza: Global CDMO with peptide, oligonucleotide, and bioconjugate manufacturing capabilities across mammalian and chemical synthesis. Competes with Creative Peptides in GMP peptide and peptide-oligonucleotide services but as part of a much broader portfolio.
• Curia (formerly AMRI): Large CDMO offering peptide API manufacturing and related services among its broader small-molecule and biologics portfolio. Comparable in CDMO positioning but at significantly greater scale and breadth.
• WuXi AppTec / WuXi Biologics: Global CRO/CDMO with growing peptide and bioconjugate manufacturing capabilities. Represents the scale-driven competitive threat Creative Peptides faces in winning large pharma outsourcing contracts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/creativepeptide
• Facebookfacebook.com/1682265715246060
• LinkedInlinkedin.com/company/creative-peptides

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creative Peptides